A Modeling and Simulations Framework to Support Global Regulatory Strategies for Pediatric Drug Development Programs

Therapeutic Innovation & Regulatory Science
Jean-Francois MarierJeffrey S Barrett

Abstract

Trial simulations have emerged as a promising tool to optimize pediatric drug development programs. As the current FDA legislation on pediatric drugs and devices was updated to mirror the EMA legislation, pediatric programs must be developed with global strategies that support a Pediatric Investigation Plan (PIP) for the EMA and a Pediatric Study Plan (PSP) for the FDA. A pharmacometrics framework is proposed to support global regulatory strategies for pediatric drug development programs. The framework describes specific trigger points and opportunities for applying modeling and simulation techniques to design the PIP and PSP and ultimately optimize pediatric drug development programs. The development of pediatric protocols by simulations and execution plans is deemed critical in defining expectations and ensuring the future success of these global programs. This can lead to clinical trial designs that are more efficient, less prone to failure, and ultimately, less costly.

References

Mar 1, 1997·Clinical Pharmacology and Therapeutics·L B Sheiner
Dec 16, 2005·The AAPS Journal·Bernd MeibohmJeffrey S Barrett
Dec 16, 2005·The AAPS Journal·Venkatesh A BhattaramJogarao V S Gobburu
Jan 30, 2007·Clinical Pharmacology and Therapeutics·L J Lesko
Feb 8, 2007·JAMA : the Journal of the American Medical Association·Jennifer S LiDaniel K Benjamin
Mar 12, 2008·Hypertension·Daniel K BenjaminJennifer S Li
Apr 28, 2009·European Journal of Clinical Pharmacology·Saskia N de Wildt, Catherijne A J Knibbe
Jun 18, 2009·Journal of Clinical Pharmacology·Stephanie LäerBernd Meibohm
Oct 15, 2010·Journal of Clinical Pharmacology·Pravin R Jadhav, Steven E Kern
Jan 20, 2011·European Journal of Clinical Pharmacology·Francesco Bellanti, Oscar Della Pasqua
Jun 7, 2012·Clinical Pharmacology and Therapeutics·J S BarrettB Meibohm
Dec 12, 2012·British Journal of Clinical Pharmacology·Johan G C van HasseltAlwin D R Huitema
Nov 29, 2010·Pharmaceutics·Jochen ZisowskyJasper Dingemanse

❮ Previous
Next ❯

Citations

May 1, 2014·Therapeutic Innovation & Regulatory Science·Stephen P Spielberg

❮ Previous
Next ❯

Methods Mentioned

BETA
pharmacotherapy

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.